• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY ORTHOPAEDICS INC US SIGMA PLI XLK INS 2.5 10MM; SIGMA KNEE PRIMARY : KNEE TIBIAL INSERT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY ORTHOPAEDICS INC US SIGMA PLI XLK INS 2.5 10MM; SIGMA KNEE PRIMARY : KNEE TIBIAL INSERT Back to Search Results
Model Number 1581-02-110
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemorrhage/Bleeding (1888); Pain (1994); Discomfort (2330); Swelling/ Edema (4577)
Event Date 03/15/2022
Event Type  Injury  
Event Description
Clinical adverse event received for swelling, hemarthrosis.Event is not serious and is considered mild.Event is possibly related to both device and procedure.Date of implant: (b)(6) 2022.Date of event: (b)(6) 2022.(right knee).Treatment: aspiration/drainage and oral medication (celebrex).
 
Manufacturer Narrative
Product complaint #: (b)(4).Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Event Description
(b)(6) 2022: the patient underwent a successful right primary total knee arthroplasty using pfc sigma components and depuy 1 cement.The patella was resurfaced.(b)(6) 2022: the patient has increasing pain and discomfort, primarily over the medial and lateral aspect of the patella.Moderate effusion was noted.An aspiration was done, which showed bloody fluid.He was also treated with antibiotics and celebrex.(b)(6) 2022: the patient was squatting in therapy and felt a pop with increasing pain.Xray show a small nondisplaced fracture across the inferior pole of the patella.This is treated with a brace for six weeks.(b)(6) 2022: the patellar fracture remains stable.The patient c/o stiffness from wearing the brace and was told he can now do range of motion and walking.It is questionable whether he avulsed a little bit of the tendon from the bone.No further intervention planned at this time outside of slowly increasing his activity level.
 
Manufacturer Narrative
Product complaint # (b)(4).This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by depuy synthes joint reconstruction, or its employees that the report constitutes an admission that the product, depuy synthes joint reconstruction, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Manufacturer Narrative
Product complaint # (b)(4).Investigation summary - the device associated with this report was not received for examination.Based on the visual analysis of the provided photographic evidence for, it cannot be determinate a depuy's device failure or malfunction which could contribute to reported event.Depuy synthes considers the investigation closed at this time.Should additional information be received, the information will be reviewed, and the investigation may be re-opened as necessary.Device history lot - the product investigation found no evidence suspecting an error in the manufacturing or material that would be a contributing factor in the reported allegation(s).A manufacturing records evaluation (mre) was not performed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SIGMA PLI XLK INS 2.5 10MM
Type of Device
SIGMA KNEE PRIMARY : KNEE TIBIAL INSERT
Manufacturer (Section D)
DEPUY ORTHOPAEDICS INC US
700 orthopaedic drive
warsaw IN 46581 0988
Manufacturer (Section G)
DEPUY IRELAND - 9616671
loughbeg, ringaskiddy co
cork
EI  
Manufacturer Contact
kate karberg
700 orthopaedic dr.
warsaw, IN 46581-0988
3035526892
MDR Report Key15966104
MDR Text Key305342137
Report Number1818910-2022-25147
Device Sequence Number1
Product Code JWH
UDI-Device Identifier10603295062431
UDI-Public10603295062431
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K082500
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 12/12/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/13/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number1581-02-110
Device Catalogue Number158102110
Device Lot Number9798063
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/27/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/30/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
DEPUY CMW 1 40G.; PFC*SIGMA C/R NPOR FEM RT SZ 3.; PFC*SIGMA/OV/DOME PAT 3PEG,35.; SIG MOD TIB TRAY CEM COCR 2.5.; SIGMA PLI XLK INS 2.5 10MM.
Patient Outcome(s) Required Intervention;
Patient Age76 YR
Patient SexMale
Patient Weight77 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-